Menu

Mini Brains Model Zika Infection

Researchers create cerebral organoids in 3-D–printed bioreactors that can be used to model Zika infection.

Apr 22, 2016
Tanya Lewis

Brain organoid infected with Zika virusJOHNS HOPKINS UNIVERSITY, XUYU QIANScientists continue to develop new methods to study Zika virus infections in vitro. Researchers at Johns Hopkins University have now created realistic brain organoids inside miniature, 3-D–printed spinning bioreactors. By infecting the mini brains with the virus, the researchers showed that it preferentially infects neural stem cells during the first trimester of pregnancy, according to the study published today (April 22) in Cell.

“The data from the Zika virus really highlights the power of this model system where we can study different stages of the disease and look at the mechanisms behind infection,” study coauthor Hongjun Song of Johns Hopkins said in a statement.

Song, his wife, Guo-li Ming, also of Johns Hopkins, and their colleagues designed the 3-D–printed mini bioreactors, and used them to grow organoids from human stem cells mimicking three brain regions: the forebrain, midbrain, and hypothalamus. The idea for the bioreactors actually came from three high school students working in the lab, including the couple’s son, according to a press release.

The resulting organoids were more cost-effective and uniform than those developed by other methods, and recapitulated many features of human brain development, including forming distinct cortical layers and expressing neuron-specific genes, the team reported.

Next, the researchers infected the forebrain organoids with Zika, to model the virus’s effect on developing fetuses. The virus preferentially attacked neural progenitors, killing cells and reducing cell layer thickness, as is seen in microcephaly. “The organoids are much smaller and they’re not generating neurons efficiently when they are infected with the Zika virus,” Ming said in the press release.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.